Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

The in-vitro colorectal cancer screening tests market is set for significant growth, driven by advancements in diagnostics ...

Nova Scotia's colorectal cancer screening program sends kits to all Nova Scotians aged 50 to 74 every two years. It is aimed at early detection and prevention. The strategy has inspired copies ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your ...

One of Nova Scotia's cancer screening strategies may be getting revamped thanks to students at NSCAD University in Halifax. Nova Scotia's colorectal cancer screening program sends kits to all Nova ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

People are three times more likely to undergo at-home colon cancer screening if they're provided a free test, a new study says. About 30% of patients mailed a free stool test kit completed their ...